دورية أكاديمية
331 (PB111) - TP53 mutations are frequently concurrent in patients with BRAF V600E mutated solid tumors and is associated with shorter duration of response to BRAF targeted therapy
| العنوان: | 331 (PB111) - TP53 mutations are frequently concurrent in patients with BRAF V600E mutated solid tumors and is associated with shorter duration of response to BRAF targeted therapy |
|---|---|
| المؤلفون: | Eriksen, M., Yde, C.W., Ahlborn, L.B., Qvortrup, C., Lassen, U., Højgaard, M., Spanggaard, I., Rohrberg, K.S. |
| المصدر: | In European Journal of Cancer October 2022 174 Supplement 1:S118-S118 |
| قاعدة البيانات: | ScienceDirect |
Full Text via ClinicalKey 
Full Text Finder | تدمد: | 09598049 |
|---|---|
| DOI: | 10.1016/S0959-8049(22)01115-7 |